Stockreport

Iovance Biotherapeutics: Base-Case Q3 Report Keeps 'Show Me' Mode [Seeking Alpha]

Iovance Biotherapeutics, Inc.  (IOVA) 
Last iovance biotherapeutics, inc. earnings: 2/25 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: iovance.com
PDF Q3 revenue landed in the base case at $68 million, missing estimates, while gross margin improved to 29.6% (=30% adjusted for D&A). Management reaffirmed FY25 revenue [Read more]